Skip to main content
. 2021 Apr 22;16(5):733–739. doi: 10.1016/j.jtumed.2021.03.007

Table 1.

Clinicopathological characteristics of patients.

Variables Frequency (n = 19)
Age
>40 15 (78.9%)
≤40 4 (21.1%)
Gender
Male 16 (84.2%)
Female 3 (15.8%)
Habits
Chewed tobacco 12 (63.1%)
Smoked tobacco 6 (31.6%)
No habit 1 (5.3%)
Tumour site
Buccal mucosa 8 (42.1%)
Mandible 3 (15.8%)
Tongue 3 (15.8%)
Retromolar trigone 3 (15.8%)
Maxilla 2 (10.5%)
Tumour size
pT2 4 (21.1%)
pT3 7 (36.8%)
pT4a 8 (42.1%)
Tumour grade
Well differentiated 3 (15.8%)
Moderately differentiated 12 (63.2%)
Poorly differentiated 4 (21.1%)
Nodal Status
Yes 12 (63.2%)
No 7 (36.8%)
pTNMstaging
pT2, pN0, pMx 2 (10.5%)
pT2, pN1, pMx 2 (10.5%)
pT3, pN0, pMx 1 (5.3%)
pT3, pN1, pMx 1 (5.3%)
pT3, pN2a, pMx 1 (5.3%)
pT3, pN2b, pMx 4 (21.1%)
pT4a, pN0, pMx 4 (21.1%)
pT4a, pN1, pMx 2 (10.5%)
pT4a, pN2b, pMx 2 (10.5%)

pTNM = pathological tumour node metastasis staging College of American Pathologists (CAP) protocol for lip & oral cavity cancer).